Corelab Data Services
Clinilabs Drug Development Corporation is a leading provider of core laboratory data services for clinical trials. Our high-performance platform connecting investigator sites and sponsors around the world to a validated and secure electronic data environment in the United States. Clinilabs corelab data services center hosts seven core laboratories that aggregate and centrally process data from multicenter clinical trials.
Corelab Data Services Value
The value of our corelab data services is its ability to reduce statistical variance in clinical datasets. By processing data centrally, rather than having data scored or reported by individual investigator sites, we are able to significantly reduce variation. Furthermore, enabling sponsors to determine the differences between treatment conditions more accurately in a clinical trial. In some cases, sponsors who have suffered a failed trial have successfully repeated the same study using our corelab processing.
Industry-Leading Expertise
Clinilabs’ corelab data services offer industry-leading operational expertise, physical and electronic security systems, as well as a high-performance network infrastructure to enable the centralized capture and processing of clinical trial data. The corelab provides clients with a turnkey solution, offering investigator sites qualification, device management, study-wide SOPs, centralized processing with rapid turnaround times in addition to 24/7 helpdesk system.
Clinilabs provides the following data types:
All truths are easy to understand once they are discovered; the point is to discover them.
If you think compliance is expensive, try non-compliance.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
One sometimes finds what one is not looking for.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
One never notices what has been done; one can only see what remains to be done.
I have no ideology. My ideology is health.
The reward for work well done is the opportunity to do more.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
The best way to predict the future is to invent it.
The pace of discovery is going unbelievably fast.
I am not accustomed to saying anything with certainty after only one or two observations.
There is so much more to be done; the patients are waiting.
Drugs don’t work in patients who don’t take them.
Good information is the best medicine.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.